Gevo, Inc. (GEVO), the Englewood, Colorado-based renewable fuels, chemicals, and carbon management company, is covered by a small but divided group of analysts. Four current, individually attributed targets were reviewed, producing a range of approximately $1.70 to $14 and a calculated mean of about $5.24, rounded to $5. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
The spread is extreme. Jefferies initiated coverage with a Hold and a $1.70 target in September 2026, while UBS maintained a Hold with a $2.00 target in May 2026. On the bullish side, Northland Securities analyst Jeff Grampp raised the firm's target to $3.25 from $3 with an Outperform rating in November 2026, and H.C. Wainwright reiterated a Buy with a $14 target. The overall rating leans positive—two Buy ratings and two Hold ratings—but the fourfold gap between the lowest and highest targets signals that analysts cannot agree on how much of Gevo's future value is already de-risked.
Gevo's latest verified share price is about $1.70, with a market capitalization near $406 million and a 52-week range of roughly $1.37 to $2.97. A move to $5 would represent an approximate 194% increase—a very large advance by any standard, and one that would carry the stock well above its prior 52-week high.
The path would require far more than the company's recent operational improvement. Gevo reported record third-quarter 2026 revenue of about $83 million, up 94% year over year, and returned to profitability with net income of roughly $23 million, supported by about $29.4 million in Canadian Clean Fuel Regulation credit sales. Yet reaching $5 likely depends on executing the ATJ-30 sustainable aviation fuel (SAF) plant in North Dakota, securing project financing, and convincing the market to assign a materially higher valuation to assets that are still largely pre-commercial.
Several verified developments underpin the bullish case. The company sold $70 million of Section 45Z Clean Fuel Production Tax Credits and now expects 2026 adjusted EBITDA to exceed $90 million, with $70 million forecast for 2027. A debottlenecking project at the North Dakota ethanol facility is nearing completion, targeting about 75 million gallons of annual capacity, with a potential expansion that could roughly double output and carbon-capture capacity from 2028. Growing carbon-credit and low-carbon fuel incentive revenue provides a foundation that some analysts argue justifies a higher average analyst price target over a 12-month horizon.
The obstacles are substantial. In April 2026, Gevo withdrew its U.S. Department of Energy loan guarantee application for the ATJ-30 project because the required enhanced oil recovery objectives were not commercially viable locally, and it has since been pursuing alternative financing it hopes to complete by the end of 2026. That financing is not yet secured. A large portion of near-term earnings depends on policy credits such as 45Z and Canadian CFR incentives, which are subject to regulatory change, and the company has historically posted significant GAAP (generally accepted accounting principles) net losses. Low oil prices, execution risk on capital-intensive projects, and potential equity dilution all weigh against the target.
At roughly $1.70, GEVO sits in the lower half of a 52-week range between about $1.37 and $2.97. The $5 target is far above the prior high, so there is no nearby resistance level between the current price and the objective. On the downside, the $1.37 area represents a meaningful support level, and the $3 round number marks a notable prior ceiling. The stock's extended history of volatility—with numerous double-digit single-day moves—underscores the wide gap between price and the bullish targets.
Analyst price targets typically reflect a research horizon of roughly 12 months, though the stated horizons of individual firms may differ. The most important items to monitor are the outcome of Gevo's effort to finance the ATJ-30 project, progress on the North Dakota debottlenecking and expansion, quarterly earnings and adjusted EBITDA trends, and any changes to federal and Canadian clean-fuel tax credit rules that directly affect the company's earnings. Carbon-credit pricing and SAF offtake agreements are also central to the long-term thesis.
The $5 central target is a calculated average of four analyst price targets, not a forecast of what the stock will do, and it sits far above both the current price near $1.70 and the 52-week high. Reaching it would require a very large move of roughly 194%, supported by genuine operational momentum—record revenue, profitability, and carbon-credit income—but contingent on financing and execution milestones that remain unresolved. The enormous $1.70-to-$14 range of targets shows that even the analysts covering the company disagree sharply about its worth. Investors should weigh the improving cash-generation story against the financing, policy, and dilution risks rather than treating the average target as a likely outcome.
I have found Tickeron's AI Daily Buy/Sell Signals useful for tracking names like this one. The tool applies artificial intelligence to scan thousands of stocks and ETFs in real time, producing Buy, Sell, or Hold signals based on technical behavior and market shifts. For investors following volatile names like GEVO, it offers a practical way to stay on top of changing conditions alongside fundamental work.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Harry Richardson — Algorithmic Trader & Strategy Developer Harry is an algorithmic trader specializing in impulse and breakout trading strategies across cryptocurrency and equity markets. With more than 10 years of experience in developing automated trading systems, he focuses on building structured algorithms designed to capture momentum while maintaining strict risk control. His approach combines quantitative analysis, real-market execution, and continuous performance monitoring. Vitalii prioritizes risk management, drawdown control, and strategy stability over short-term optimization, ensuring algorithms are adaptable to changing market conditions. He has developed and tested hundreds of automated strategies, working extensively with live trading environments, forward testing, and portfolio-level algorithm management. His work centers on transforming trading ideas into fully operational, scalable automated systems.
GEVO broke above its upper Bollinger Band on November 11, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 35 similar instances where the stock broke above the upper band. In 31 of the 35 cases the stock fell afterwards. This puts the odds of success at 89%.
The 10-day RSI Indicator for GEVO moved out of overbought territory on November 16, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 28 similar instances where the indicator moved out of overbought territory. In 22 of the 28 cases, the stock moved lower in the following days. This puts the odds of a move lower at 79%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 40 of 52 cases where GEVO's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 77%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where GEVO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.
The Momentum Indicator moved above the 0 level on October 28, 2026. You may want to consider a long position or call options on GEVO as a result. In 75 of 93 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 81%.
The Moving Average Convergence Divergence (MACD) for GEVO just turned positive on October 27, 2026. Looking at past instances where GEVO's MACD turned positive, the stock continued to rise in 35 of 48 cases over the following month. The odds of a continued upward trend are 73%.
GEVO moved above its 50-day moving average on November 06, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for GEVO crossed bullishly above the 50-day moving average on November 12, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
Following a +33.81% 3-day Advance, the price is estimated to grow further. Considering data from situations where GEVO advanced for three days, in 187 of 222 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
The Aroon Indicator entered an Uptrend today. In 110 of 143 cases where GEVO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 77%.
The Tickeron PE Growth Rating for this company is 24 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. GEVO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 38 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.258) is normal, around the industry mean (2.284). P/E Ratio (-1.544) is within average values for comparable stocks, (-17.137). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.548). Dividend Yield (0.000) settles around the average of (0.039) among similar stocks. P/S Ratio (2.012) is also within normal values, averaging (48.960).
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GEVO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a company which engages in the development and commercialization of alternatives to petroleum-based products
Industry ChemicalsSpecialty